why choose us

First received: June 01, 2023

Clinical Trial: A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy

Study Type: INTERVENTIONAL


Official Title: A Non-randomised, Open-label Phase I Trial to Evaluate the Effect of BI 456906 at Different Dose Levels of Multiple Subcutaneous Doses in a Titration Scheme on the Single Dose Pharmacokinetics of a Co

Brief Summary: This study is open to women with overweight or obesity who are otherwise healthy.Women with a body mass index (BMI) from 27 to 40 kg/m2 can participate.The purpose of this study is to find out whether taking multiple doses of BI 456906 influences the amount of ethinylestradiol and levonorgestrel in the blood.Ethinylestradiol and levonorgestrel are ingredients of the contraceptive Microgynon®.The study has 2 treatment periods.In Period 1, participants get 1 tablet of Microgynon®.In Period 2, participants get…

Read more